GSTM5 and urinary bladder carcinoma: In our previous study [24], GSTM5 mRNA expression was enhanced in 5637 bladder cancer cells following treatment with 10 μM 5-aza-dC; the DNA CpG methylation level of the GSTM5 promoter was also decreased from 84.6 to 61.5%.